Liboran

Acetylcysteine, the active ingredient in Liboran, is a mucolytic agent presented as an oral formulation for systemic use. It reduces the viscosity of respiratory tract secretions and is used to facilitate mucus clearance in patients with various respiratory conditions. Available over‑the‑counter in the European market, the product is formulated for oral administration and does not require a prescription.

GNH USA supplies Liboran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation upon request.

Acetylcysteine is a mucolytic that acts on respiratory secretions to improve clearance.

- Chronic obstructive pulmonary disease (COPD): enhances sputum expectoration and reduces airway obstruction. - Cystic fibrosis: lowers mucus viscosity, facilitating airway hygiene. - Acute bronchitis: aids in the removal of thickened secretions. - Bronchopulmonary infections: supports mucus clearance to improve ventilation. - Post‑operative airway management: helps prevent retention of secretions after surgery.

Acetylcysteine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools may appear. - Metallic taste: transient alteration of taste perception.

Serious or Rare Side Effects: - Anaphylactic reaction: sudden swelling, rash, or difficulty breathing. - Bronchospasm: tightening of airway muscles, especially in asthmatic patients. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: abnormal liver enzyme elevations. - Neutropenia: reduced white blood cell count.

When using Liboran, consider the following safety measures.

- Pregnancy: consult a healthcare provider before use. - Breastfeeding: use with caution and under medical advice. - Renal impairment: dose adjustment may be required. - Asthma: monitor for possible bronchospasm. - Concurrent mucolytics: avoid duplicate therapy. - Store at room temperature: keep in the original pack, protect from moisture.

Acetylcysteine may interact with other medicines; monitor as indicated.

Major Interactions (Avoid): - Activated charcoal: can significantly reduce drug absorption. - Nitroglycerin: may enhance hypotensive effects.

Moderate Interactions (Monitor Closely): - Aminoglycoside antibiotics: watch renal function. - Bronchodilators: assess for additive respiratory effects. - Antihistamines: may increase sedation or drowsiness.